DYSLIPIDEMIA PREVALENCE, PATTERNS, AND ASSOCIATED FACTORS IN TYPE 2 DIABETES MELLITUS PATIENTS: A CROSS-SECTIONAL STUDY.”
Main Article Content
Keywords
Type 2 diabetes mellitus, Dyslipidemia, Lipid profile, Cardiovascular risk, Cross-sectional study.
Abstract
Background: Dyslipidemia is a common metabolic disorder in patients with type 2 diabetes mellitus and is regarded as the key risk factor behind cardiovascular diseases. The presence of abnormal lipid patterns in combination with chronic hyperglycemia increases the progression of atherosclerosis and other diabetic issues. The knowledge of the widespread and dynamic dyslipidemia in diabetic patients is relevant in enhancing clinical care and decreasing the complications in the long run.
Objective: The primary aim of the study was to identify the prevalence, trends, and determinants of dyslipidemia in patients with type 2 diabetes mellitus who attended Primary health care centers.
Methods: The study is a cross-sectional investigation between January 2025 and December 2025. The study used 16 patients diagnosed with type 2 diabetes mellitus. The structured data collection form was used in demographic and clinical data collection. Blood samples were taken fast to test the parameters of lipid profiles such as total cholesterol, triglycerides, low-density lipoprotein cholesterol, and high-density lipoprotein cholesterol. The condition of dyslipidemia was determined by the presence of abnormal lipids as per the standard clinical guidelines. The statistical techniques applied in the analysis of data were descriptive.
Results: The results showed that 68 percent of the research subjects had dyslipidemia. The most prevalent lipid disorders were low high-density lipoprotein cholesterol and high levels of triglycerides. Patients aged over 50 years and those who had been affected by diabetes for a long period were more likely to show dyslipidemia. The prevalence was higher in male patients than in female patients.
Conclusion: The occurrence of dyslipidemia is very high in type 2 diabetes mellitus patients. Early interventions and screening of lipids are necessary to minimize cardiovascular risk and enhance the overall outcomes among diabetic patients.
References
2. Haq AU, Usman K, Ullah N, Hassan T, Akhtar J, Ullah I. A cross-sectional study on prevalence and pattern of dyslipidemia and its associated factors among patients with type 2 diabetes mellitus. Age (years). 2023;58:6–8.
3. Hyassat D, Al-Saeksaek S, Naji D, Mahasneh A, Khader Y, Abujbara M, El-Khateeb M, Ajlouni K. Dyslipidemia among patients with type 2 diabetes in Jordan: prevalence, pattern, and associated factors. Frontiers in Public Health. 2022;10:1002466.
4. Bawah AT, Darko R, Abaka-Yawson A, Seini MM, Kinanyok S, Adusei S. Dyslipidemia and its associated factors in patients with type 2 diabetes mellitus. Journal of Public Health. 2021;29(4):985-991.
5. Al Ghadeer HA, Al Barqi M, Almaqhawi A, Alsultan AS, Alghafli JA, AlOmaish MA, AlGhanem ZA, Alsaqar AH, Alatiyyah AT, Alburayh YA, AlOmair A. Prevalence of dyslipidemia in patients with type 2 diabetes mellitus: a cross-sectional study. Cureus. 2021;13(12).
6. Li J, Nie Z, Ge Z, Shi L, Gao B, Yang Y. Prevalence of dyslipidemia, treatment rate and its control among patients with type 2 diabetes mellitus in Northwest China: a cross-sectional study. Lipids in Health and Disease. 2022;21(1):77.
7. Ahmmed MS, Shuvo SD, Paul DK, Karim MR, Kamruzzaman M, Mahmud N, Ferdaus MJ, Elahi MT. Prevalence of dyslipidemia and associated risk factors among newly diagnosed type-2 diabetes mellitus patients in Kushtia, Bangladesh. PLOS Global Public Health. 2021;1(12):e0000003.
8. Kebede WM, Gizachew KD, Mulu GB. Prevalence and risk factors of dyslipidemia among type 2 diabetes patients at a referral hospital, North Eastern Ethiopia. Ethiopian Journal of Health Sciences. 2021;31(6).
9. Mehta RK, Koirala P, Mallick RL, Parajuli S, Jha R. Dyslipidemia in patients with type 2 diabetes mellitus in a tertiary care centre: a descriptive cross-sectional study. JNMA: Journal of the Nepal Medical Association. 2021;59(236):305.
10. Yadegar A, Mohammadi F, Rabizadeh S, Qahremani R, Esteghamati A, Nakhjavani M. Prevalence of different patterns of dyslipidemia in patients with type 2 diabetes in an Iranian population. Translational Medicine Communications. 2022;7(1):23.
11. Lokpo SY, Laryea R, Osei-Yeboah J, Owiredu WK, Ephraim RK, Adejumo EN, Ametepe S, Appiah M, Peter N, Affrim P, Kwadzokpui PK. The pattern of dyslipidaemia and factors associated with elevated levels of non-HDL cholesterol among patients with type 2 diabetes mellitus in the Ho municipality: a cross sectional study. Heliyon. 2022;8(8).
12. Kamrul-Hasan AB, Alam MS, Zarin N, Kabir MA, Gaffar AJ, Hossain MF, Talukder SK, Raunak AI, Nabi MM, Asaduzzaman M, Hasan MJ. Prevalence and patterns of dyslipidemia among lipid-lowering drug-naïve patients with type 2 diabetes mellitus: a countrywide study in Bangladesh. Endocrine and Metabolic Science. 2023;13:100152.
13. Abera A, Worede A, Hirigo AT, Alemayehu R, Ambachew S. Dyslipidemia and associated factors among adult cardiac patients: a hospital-based comparative cross-sectional study. European Journal of Medical Research. 2024;29(1):237.
14. Abdissa D, Hirpa D. Dyslipidemia and its associated factors among adult diabetes outpatients in West Shewa zone public hospitals, Ethiopia. BMC Cardiovascular Disorders. 2022;22(1):39.
15. Gebreegziabiher G, Belachew T, Mehari K, Tamiru D. Prevalence of dyslipidemia and associated risk factors among adult residents of Mekelle City, Northern Ethiopia. PLOS One. 2021;16(2):e0243103.
16. Alıcı G, Genç Ö. The pattern of dyslipidemia among Somali type 2 diabetic patients: a cross-sectional study. European Journal of Medical Research. 2022;27(1):253.
17. Yadegar A, Mohammadi F, Rabizadeh S, Ayati A, Seyedi SA, Nabipoorashrafi SA, Esteghamati A, Nakhjavani M. Correlation between different levels and patterns of dyslipidemia and glomerular filtration rate in patients with type 2 diabetes: a cross-sectional survey of a regional cohort. Journal of Clinical Laboratory Analysis. 2023;37(13-14):e24954.
18. Kelemework B, Woubshet K, Tadesse SA, Eshetu B, Geleta D, Ketema W. The burden of dyslipidemia and determinant factors among type 2 diabetes mellitus patients at Hawassa University Comprehensive Specialized Hospital, Ethiopia. Diabetes, Metabolic Syndrome and Obesity. 2024;17:825-832.
Article Sidebar
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All articles published in JPTCP are licensed under Copyright Creative Commons Attribution-NonCommercial 4.0 International License.
